Cheryl R Blanchard - Net Worth and Insider Trading

Cheryl R Blanchard Net Worth

The estimated net worth of Cheryl R Blanchard is at least $2 Million dollars as of 2024-05-12. Cheryl R Blanchard is the President, CEO, Director of Anika Therapeutics Inc and owns about 59,992 shares of Anika Therapeutics Inc (ANIK) stock worth over $2 Million. Details can be seen in Cheryl R Blanchard's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cheryl R Blanchard has not made any transactions after 2022-03-11 and currently still holds the listed stock(s).

Transaction Summary of Cheryl R Blanchard

To

Cheryl R Blanchard Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cheryl R Blanchard owns 6 companies in total, including Dare Bioscience Inc (DARE) , Neuronetics Inc (STIM) , and Anika Therapeutics Inc (ANIK) among others .

Click here to see the complete history of Cheryl R Blanchard’s form 4 insider trades.

Insider Ownership Summary of Cheryl R Blanchard

Ticker Comapny Transaction Date Type of Owner
DARE Dare Bioscience Inc 2019-11-20 director
STIM Neuronetics Inc 2019-02-13 director
ANIK Anika Therapeutics Inc 2022-03-11 director
2015-07-01 director
2005-05-02 VP - Corporate Research
2022-01-06 director

Cheryl R Blanchard Latest Holdings Summary

Cheryl R Blanchard currently owns a total of 1 stock. Cheryl R Blanchard owns 59,992 shares of Anika Therapeutics Inc (ANIK) as of March 11, 2022, with a value of $2 Million.

Latest Holdings of Cheryl R Blanchard

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANIK Anika Therapeutics Inc 2022-03-11 59,992 25.63 1,537,595

Holding Weightings of Cheryl R Blanchard


Cheryl R Blanchard Form 4 Trading Tracker

According to the SEC Form 4 filings, Cheryl R Blanchard has made a total of 1 transactions in Anika Therapeutics Inc (ANIK) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Anika Therapeutics Inc is the acquisition of 8,100 shares on March 11, 2022, which cost Cheryl R Blanchard around $207,117.

Insider Trading History of Cheryl R Blanchard

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cheryl R Blanchard Trading Performance

GuruFocus tracks the stock performance after each of Cheryl R Blanchard's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cheryl R Blanchard is -17.83%. GuruFocus also compares Cheryl R Blanchard's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cheryl R Blanchard within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cheryl R Blanchard's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cheryl R Blanchard

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -6.45
Relative Return to S&P 500(%) -11.4

Cheryl R Blanchard Ownership Network

Ownership Network List of Cheryl R Blanchard

No Data

Ownership Network Relation of Cheryl R Blanchard


Cheryl R Blanchard Owned Company Details

What does Dare Bioscience Inc do?

Who are the key executives at Dare Bioscience Inc?

Cheryl R Blanchard is the director of Dare Bioscience Inc. Other key executives at Dare Bioscience Inc include director & Chef Executive Officer Sabrina Martucci Johnson , Chief Strategy Officer John A Fair , and Chief Financial Officer Lisa Walters-hoffert .

Dare Bioscience Inc (DARE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Dare Bioscience Inc (DARE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dare Bioscience Inc (DARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dare Bioscience Inc (DARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Dare Bioscience Inc Insider Transactions

No Available Data

Cheryl R Blanchard Mailing Address

Above is the net worth, insider trading, and ownership report for Cheryl R Blanchard. You might contact Cheryl R Blanchard via mailing address: C/o Zimmer, Inc., P.o. Box 708, Warsaw In 46580.

Discussions on Cheryl R Blanchard

No discussions yet.